发明名称 Hemocompatibility Modifiers for Cross-Linked Polymeric Material
摘要 The invention concerns methods of treating blood, blood product, or physiologic fluid to provide at least one of (i) increasing shelf life of the blood, blood product or physiologic fluid, (ii) maintaining freshness of new blood, blood product or physiologic fluid, and (iii) removing undesirable molecules from the blood, blood product or physiologic fluid; said method comprising contacting said blood, blood product or physiologic fluid with a sorbent, said sorbent being primarily in a plurality of solid forms and comprising a cross-linked polymeric material having a plurality of at least one of (1) zwitterionic moieties and (2) oligo(ethylene glycol) moieties attached to the surface of said cross-linked polymeric material.
申请公布号 US2014294751(A1) 申请公布日期 2014.10.02
申请号 US201414230108 申请日期 2014.03.31
申请人 CytoSorbents Corporation 发明人 Golobish Thomas D.;Capponi Vincent J.;Clay David R.
分类号 A61M1/36;A61K31/785;A61K31/765;A61M1/34 主分类号 A61M1/36
代理机构 代理人
主权项 1. A method of treating blood, blood product, plasma or physiologic fluid to provide at least one of (i) increasing shelf life of the blood, blood product or physiologic fluid, (ii) maintaining freshness of new blood, blood product or physiologic fluid, and (iii) removing undesirable molecules from the blood, blood product or physiologic fluid; said method comprising contacting said blood, blood product or physiologic fluid with a sorbent, said sorbent being primarily in a plurality of solid forms and comprising a cross-linked polymeric material having a plurality of at least one of (1) zwitterionic moieties and (2) oligo(ethylene glycol) moieties attached to the surface of said cross-linked polymeric material.
地址 Monmouth Junction NJ US
您可能感兴趣的专利